Screener
Adaptive Biotechnologies ADPT Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $169.87M+294% | $77.58M+53.2% | $70.5M+47.1% | $55.03M+44.5% | $43.16M-27.9% | ||
| $174.38M+12.7% | $140.75M-1.4% | $156.49M-10.3% | $157.74M-23.1% | $154.71M-33.3% | ||
| $49.51M+11.8% | $48.32M+10.9% | $50.37M+20.7% | $44.82M+9.8% | $44.29M+24.4% | ||
| $10.5M+24.9% | $11.21M+29.0% | $9.82M+16.4% | $9.93M-16.9% | $8.4M-36.4% | ||
| $420.56M+60.6% | $291.81M+13.8% | $300.19M+5.8% | $281.44M-8.7% | $261.86M-25.5% | ||
| $29.45M-28.3% | $30.77M-30.7% | $34.11M-29.8% | $37.5M-26.9% | $41.06M-25.9% | ||
| $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | ||
| $884K-65.8% | $1.31M-56.5% | $1.73M-49.6% | $2.16M-44.1% | $2.58M-39.7% | ||
| $640.68M+29.0% | $505.94M-1.0% | $512.74M-4.9% | $490.61M-12.2% | $496.64M-15.1% | ||
| $5.24M-24.1% | $9.62M+51.1% | $6.47M-11.0% | $10.27M+39.7% | $6.91M-30.0% | ||
| $53.26M-3.7% | $49.4M-9.9% | $45.19M-18.8% | $41.34M-20.3% | $55.3M+5.9% | ||
| $0-100% | $5.8M+189% | $4.64M+437% | $2.43M— | $3.07M— | ||
| $87.71M-4.8% | $87.01M-0.9% | $89.92M-8.3% | $83.36M-4.9% | $92.14M+4.6% | ||
| $0-100% | $124.75M-5.2% | $126.57M-4.4% | $129.41M-2.5% | $130.5M-1.2% | ||
| $490.02M+54.5% | $281.7M-12.1% | $287.74M-14.6% | $286.36M-14.5% | $317.1M-7.7% | ||
| $16K+6.7% | $16K+6.7% | $15K+7.1% | $15K+7.1% | $15K+7.1% | ||
| -$1.42B-4.7% | -$1.38B-3.7% | -$1.36B-4.6% | -$1.35B-6.3% | -$1.36B-9.8% | ||
| $142.91M-20.5% | $216.34M+13.6% | $218.79M+7.9% | $204.44M-8.6% | $179.72M-25.6% | ||
| $640.68M+29.0% | $505.94M-1.0% | $512.74M-4.9% | $490.61M-12.2% | $496.64M-15.1% |
FAQ
- What are Adaptive Biotechnologies's total assets?
- Adaptive Biotechnologies (ADPT) holds $640.7M in total assets, up 29.0% year over year.
- How much debt does Adaptive Biotechnologies have?
- Adaptive Biotechnologies carries $75.6M in total debt against $142.9M of shareholders' equity, a debt-to-equity ratio of 0.53.
- How much cash does Adaptive Biotechnologies have?
- Adaptive Biotechnologies holds $169.9M in cash and equivalents.
- Can Adaptive Biotechnologies cover its short-term obligations?
- Its current ratio is 4.79 — current assets exceed current liabilities.
- Where does Adaptive Biotechnologies's balance sheet data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
